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PathogenicityThe intriguing roles of the bacterial Tol–Pal trans-envelope protein complex range from maintenance of cell en-
velope integrity to potential participation in the process of cell division. In this study, we report the characteriza-
tion of the XfTolB and XfPal proteins of the Tol–Pal complex of Xylella fastidiosa. X. fastidiosa is a major plant
pathogen that forms bioﬁlms inside xylemvessels, triggering the development of diseases in important cultivable
plants around the word. Based on functional complementation experiments in Escherichia coli tolB and palmu-
tant strains, we conﬁrmed the role of xftolB and xfpal in outermembrane integrity. In addition, we observed a dy-
namic and coordinated protein expression proﬁle during the X. fastidiosa bioﬁlm development process. Using
small-angle X-ray scattering (SAXS), the low-resolution structure of the isolated XfTolB–XfPal complex in solu-
tion was solved for the ﬁrst time. Finally, the localization of the XfTolB and XfPal polar ends was visualized via
immunoﬂuorescence labeling in vivo during bacterial cell growth. Our results highlight the major role of the
components of the cell envelope, particularly the TolB–Pal complex, during the different phases of bacterial bio-
ﬁlm development.
© 2015 Elsevier B.V. All rights reserved.1. Introduction
One of the most important stages of niche colonization by bioﬁlm-
forming bacteria is adherence to the superﬁcies to be colonized [1,2].
The adhesion stage requires the expression of a range of proteins, in-
cluding adhesin, as well as the increased expression of lipopolysaccha-
ride on the cell surface [3,4]. Thus, the cell envelope and all the
proteins responsible for itsmaintenance are key elements of the success
of niche- and/or host-speciﬁc colonization by these microorganisms.
The Tol–Pal system is ubiquitous in Gram-negative bacteria and is
associated with cell envelope integrity [5,6]. The genes encoding the
proteins of this system are typically organized into operons and include
tolQ, tolR and tolA, which encode proteins located in the inner mem-
brane; ybgC and ybgF, which encode products of unknown function;idiosa Pal; SDS, sodium dodecyl
-angle X-ray scattering.
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elft University of Technology,and the pal and tolB genes [7–9]. Pal is a peptidoglycan-associated
outer membrane-anchored lipoprotein that resides in the periplasmic
space and is strongly associated with the peptidoglycan layer through
a conserved α-helical motif [10,11]. TolB (translocation protein TolB)
is an allosteric β-propeller protein that acts in the bacterial periplasmic
space and may interact with other proteins, including Pal [12–15] and
the cell-killing proteins categorized as group A colicins [16–18].
Nullmutants of the tol–pal genes exhibit a ‘leaky-membrane’ pheno-
type with a tendency to form vesicles on the outer membrane, reduced
expression of lipopolysaccharide on the cell surface, defects in cell divi-
sion and increased sensitivity to antibiotics and detergents [5,19,20].
Gerding et al. [21] proposed that the Tol–Pal complex is part of the
cell division machinery of Gram-negative bacteria and is required for
proper invagination of the cell envelope during cell constriction in
Escherichia coli. However, while the Tol–Pal complex clearly plays an
important role in the maintenance and integrity of the bacterial cell
envelope, the physiological role of this protein complex has not been
fully elucidated.
The tol–pal genes have been associated with the pathogenesis of
several bacteria, including Salmonella typhimurium, Vibrio cholerae,
Erwinia chrysanthemi, and Burkholderia cenocepacia [22–26]. In the
bioﬁlm-forming bacterium Pseudomonas aeruginosa, tolB is essential
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up-regulated during bioﬁlm development [28]. Consistent with its
apparent function, tolB is required for the growth of E. coli at high hydro-
static pressure (40 mPa) [29]. More recently, pal expression was
observed during the infective stage of Lawsonia intracellularis, a
fastidious, microaerophilic obligate intracellular bacterium [30]. These
results illustrate the critical role of this protein system in bacterial
virulence.
Here, we report the characterization of the XfTolB and XfPal proteins
of the Tol–Pal cell envelope complex of the plant pathogen Xylella
fastidiosa. Our ﬁndings conﬁrm the involvement of the XfTolB and
XfPal proteins in membrane integrity and demonstrate dynamic,
coordinated XfTolB and XfPal expression during the X. fastidiosa bioﬁlm
development process. Using small-angle X-ray scattering (SAXS), the
low-resolution structure of the XfTolB–XfPal complex in solution was
solved for the ﬁrst time. In addition, XfTolB and XfPal were visualized
during X. fastidiosa growth in vivo via immunolabeling. Our results
highlight the major role of the components of the cell envelope, partic-
ularly the TolB–Pal complex, during the growth of the bioﬁlm-forming
plant pathogen X. fastidiosa.2. Material and methods
2.1. Bacterial strains, plasmids and culture conditions
The bacterial strains and plasmids used in the present study are
described in Table 1. The X. fastidiosa 9a5c strain [31] and E. coli strains
DH5α (Invitrogen, Carlsbad, CA, USA), BL21 (DE3) (Novagen, Madison,
WI, USA), BW25113 [32], JW5100 and JW0731 [33] have been described
previously. X. fastidiosa was cultured in periwinkle wilt (PW) medium
[34] at 130 rpm and 28 °C, and the E. coli strains were grown in LB or
BHI broth at 200–300 rpm and 25–37 °C. When appropriate, the
medium was supplemented with 30 μg·mL−1 kanamycin and/or
100 μg·mL−1 ampicillin. The medium was also occasionally supple-
mented with L-arabinose, isopropyl-β-D-thiogalactopyranoside (IPTG)
and/or sodium dodecyl sulfate (SDS) as indicated. XfTolB and XfPal
expression constructs were prepared using standard molecular biology
techniques [35] and the plasmids pET29a (Novagen, Madison,WI, USA)
and pBAD24 [36]. Gene expression from the T7 promoter in pET29a
was induced by the addition of 0.4 mM IPTG, while gene expression
from the araCPBAD promoter in pBAD24 was induced by 0.2% (w/v)
L-arabinose.Table 1
Bacterial strains and plasmids used.
Strain or plasmid Relevant genotype and/or characteristics
Xylella fastidiosa
X. fastidiosa 9a5c Gram-negative, bioﬁlm-forming isolate that causes citrus vari
Escherichia coli
DH5α F− endA1 glnV44 thi-1 recA1 relA1 gyrA96 deoR nupG Φ80dlacZ
BL21(DE3) F− ompT gal dcm lon hsdSB λ(DE3)
BW25113 F− ΔlacZ4787(::rrnB3) hsdR514 Δ(araBAD)567 Δ(rhaBAD)568
BW25113-pBAD24 BW25113 with the arabinose-inducible empty vector pBAD24
JW5100 BW25113 ΔtolB789::kan
JW5100-pBAD24 JW5100 with the arabinose-inducible empty vector pBAD24
JW5100-pBAD24-xftolB JW5100 with an arabinose-inducible copy of xftolB in pBAD24
JW0731 BW25113 Δpal790::kan
JW0731-pBAD24 JW0731 with the arabinose-inducible empty vector pBAD24
JW0731-pBAD24-xfpal JW0731 with an arabinose-inducible copy of xfpal in pBAD24
Plasmid
pET29a Commercial vector carrying the T7 promoter system IPTG-ind
pBAD24 Vector carrying the araCPBAD arabinose-inducible promoter sy
pBAD24-xftolB pBAD24 carrying the xftolB coding sequence cloned between t
pBAD24-xfPal pBAD24 carrying the xfpal coding sequence cloned between th2.2. Cloning, expression and puriﬁcation of XfTolB and XfPal
The coding sequence of the XfTolB protein (ORF Xf1625; GenBank
accession number: WP_023906495.1) lacking the signal peptide
sequence (amino acid residues 1 to 23) was ampliﬁed by PCR from
genomic DNA of the X. fastidiosa 9a5c strain using the speciﬁc oligonu-
cleotides Xf1625F (5′-CCAAACATATGACGAAA TTTCCACGCTGG-3′) and
Xf1625R (5′-AAACTCGAGATGTACGCTCCGG TAAGGCCC-3′), which
contain restriction sites for the enzymes NdeI and XhoI, respectively.
The PCR ampliﬁcation product was cloned into the expression vector
pET29a to enable expression as a fusion with a C-terminal tag contain-
ing six histidine residues (His6-tag). The absence of base substitutions
in the recombinant plasmid was evaluated by DNA sequencing. XfTolB
was overexpressed in E. coli BL21 (DE3). The cells were cultured at
37 °C with shaking at 300 rpm in 1 L of LB broth containing kanamycin
(30 μg mL−1) until an OD600 of 0.6–0.8 was reached. Expression of the
recombinant protein was induced by adding 0.4 mM IPTG, followed by
cultivation for 16 h at 25 °C and 200 rpm. The culture was then centri-
fuged (3000 g, 15 min, 4 °C), and the cells were resuspended in 50 mL
of buffer A (50 mM Tris–Cl pH 6.5 and 300 mM NaCl) containing
1 mg·mL−1 lysozyme and 2 mM phenylmethanesulfonyl ﬂuoride
(PMSF; Sigma-Aldrich, St. Louis, MO, USA). The cells were disrupted
by sonication, and the soluble fraction was collected by centrifugation
(20,000 g, 40 min, 4 °C). XfTolB was puriﬁed by nickel afﬁnity chroma-
tography using Ni-NTA resin (Qiagen, Germany) equilibrated with
buffer A. The puriﬁed protein was eluted using an imidazole gradient
(0 to 500mM). The purity of the XfTolB protein samples was estimated
by SDS-PAGE.
The cloning, expression and puriﬁcation of XfPal lacking its signal
peptidewere performed using the protein refolding protocol previously
described by Santos et al. [37]. The concentrations of the recombinant
puriﬁed His6-tag XfTolB and XfPal proteins were determined spectro-
photometrically using calculated molar extinction coefﬁcients (ε280) of
55,810 and 16,180 M−1 cm−1, respectively.2.3. Functional complementation of xftolB and xfpal in knockout E. coli
strains
The involvement of XfTolB and XfPal in membrane integrity was
assessed in vivo using a functional complementation assay based on
the SDS sensitivity of tolB− and pal− E. coli mutants [33]. The
full-length xftolB and xfpal genes were cloned into the pBAD24 vectorReference
or source
egated chlorosis (CVC) in orange [31]
ΔM15 Δ(lacZYA-argF)U169, hsdR17, λ− Invitrogen
Novagen
rph-1 λ− [32]
This study
[33]
This study
This study
[33]
This study
This study
ucible, kanR Novagen
stem and a Shine–Dalgarno box for the translation start codon; AmpR [36]
he NcoI and SalI restriction sites This study
e NcoI and SalI restriction sites This study
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CACGCTG-3′), XfTolBBADR (5′-ACTGTCGACTTAATGTACGCTCCGGTA-
3′), XfPalBADF (5′-TACCATGGCACCAACTGTTTCTAC-3′), and XfPalBADR
(5′-CGTGTCGACTTACTTCGCTGTATAG-3′). The forward and reverse
primers contained NcoI and SalI restriction sites, respectively. The
empty pBAD24 vector or the pBAD24-xftolB or pBAD24-xfpal construct
was transformed into E. coli JW5100 (tolB deletion mutant) or JW0731
(pal deletion mutant), which were derived from the wild-type
BW25113 strain (Table 1). The wild-type and deletion mutant strains
were provided by the National BioResource Project (NIG Japan). The
SDS growth inhibitory effect was assessed using an adapted Kirby–
Bauer disc diffusion test. Brieﬂy, the strains (wild-type, tolB− and pal−
containing empty vector or the xftolB or xfpal construct) were grown
overnight in LB containing 100 μg·mL−1 ampicillin or 30 μg·mL−1
kanamycin (depending on the strain) at 37 °C and 300 rpm. The cultures
were then diluted 100-fold in Brain–Heart Infusion (BHI; HiMedia,
Mumbai, India) medium supplemented with the appropriate antibiotic
and grown at 37 °C and 300 rpm to anOD600 of 0.8. After growth, 200 μL
of cells of each culturewas individually inoculated on BHI plates supple-
mentedwith 0.2% (w/v) L-arabinose. A 5-mm-diameter ﬁlter paper disc
with 5 μL of 10% (w/v) SDS was placed on the plates, and the SDS-
associated phenotype was analyzed following incubation of the plates
at 37 °C overnight. The effect of 0.2% (w/v) SDS on cell growth was
evaluated by measuring the turbidity (OD600) every 15 min for 8 h of
bacterial growth (wild-type, mutants and mutants complemented
with xftolB or xfpal construct) in BHI liquid culture. All experiments
were performed in triplicate.
2.4. Western blotting analyses of XfTolB and XfPal expression during
X. fastidiosa bioﬁlm formation
The X. fastidiosa 9a5c strain was used to obtain different develop-
mental phases of X. fastidiosa bioﬁlm, and planktonic cells of the same
age corresponding to each bioﬁlm phasewere obtained using a protocol
established by de Souza et al. [38]. Polyclonal anti-XfTolB and anti-XfPal
antibodies were produced by Rheabiotech (Campinas, SP, Brazil) and
were used in XfTolB and XfPal immunoblotting during planktonic
growth or X. fastidiosa bioﬁlm formation. For western blot analyses,
total protein was extracted from X. fastidiosa at different stages of
bioﬁlm formation and planktonic cells and analyzed and normalized as
described by Santos et al. [39]. Approximately 5 μg of total X. fastidiosa
protein from each sample was used for the immunodetection experi-
ments. The polyclonal anti-Hsp70/Hsc70 Global (StressMarq Biosciences,
Victoria, BC, Canada) antibody for the detection of the bacterial DnaK
protein (68 kDa) was used as a loading control.
2.5. Immunoﬂuorescence labeling of XfTolB and XfPal
The immunoﬂuorescence-based localization of the XfTolB and XfPal
proteins in the X. fastidiosa 9a5c cell envelope was performed using the
polyclonal anti-XfTolB and anti-XfPal antibodies via optical detection
with Cy5-conjugated secondary antibodies (Santa Cruz Biotechnology,
USA). In order to accomplish this, n = 8 oxygen-plasma cleaned
(15 min at 50 sccm O2, 200 W, 100 mTorr; Model SE80, Barrel Asher
Plasma Technology, USA) borosilicate cover glasses (13-mm-diameter)
were placed in the bottom of a sterile 24-well Nunclon Delta S1
Multidish (Nunc, USA). Approximately 1 mL PW medium containing
100 μL of X. fastidiosa 9a5c culture (OD600 of 0.1) was added to different
multidish wells that contain the glass substrates for bacterial adhesion
and growth. After bacterial growth for 12 h at 28 °C, the medium was
gently removed and samples were washed twice for 5 min each in
phosphate-buffered saline (PBS, pH 7.4).
To slightly permeabilize the outermembrane and the peptidoglycan
layer of theGram-negative bacteria, 500 μL of lysozyme (5mg·mL−1) in
PBS was added to the wells and incubated for 60 min, followed by
washing of the wells three times with PBS for 3 min each. To reducenon-speciﬁc physisorption of the speciﬁc antibodies, 500 μL of bovine
serum albumin (BSA; 2%, w/v)-PBS blocking solution was added to
each sample well and incubated for 1 h at room temperature. After
washing the wells three times with PBS-Tween 20 (0.05% v/v) for
2 min each, the polyclonal anti-XfPal and anti-XfTolB antibodies were
added to each sample well at a concentration of 10 μg·mL−1 in PBS-
BSA and incubated for 1 h at 37 °C. The samples were then washed
three timeswith PBS-Tween20 for 2min each. Forﬂuorescence labeling
of the target proteins, 200 μL of PBS-BSA containing 1 μg·mL−1 goat
anti-rabbit Cy5-conjugated IgG (Santa Cruz Biotechnology, USA) was
added to the samples and incubated for 1 h at 37 °C, protected from
light. In a ﬁnal step, the samples were washed twice for 2 min with
PBS-Tween 20, three times with PBS for 3 min and brieﬂy with deion-
ized water and then ﬁnally dried gently in a nitrogen stream. The
immunolabeling experiments were performed six times for both XfTolB
and XfPal detection.
For target protein localization via immunoﬂuorescence labeling, the
prepared samples were examined using an epiﬂuorescence microscope
(Nikon TE2000U, USA) with a Peltier-cooled back-illuminated EMCCD
camera (Andor IXON3, 1024 × 1024 pixels; Galway, Ireland) in combi-
nation with an 100× oil-immersion objective (CFI APO TIRF, NA. 1.45,
Nikon, USA). Cy5 ﬂuorophore and bacterial autoﬂuorescence excitation
was achieved using a 150 W mercury vapor lamp with ﬁlter sets (F41-
054 and F41-008; AHF, Tübingen, Germany) for green (λex = 480 nm)
and red (λex = 640 nm) light excitation. For each immunolabeled
sample, the bacterial autoﬂuorescence in the green wavelength regime
(λem = 550/50 nm) was measured, followed by a measurement in the
red emission spectra (λem = 690/20 nm) for the localization of the
Cy5-conjugated secondary antibody. The resulting images (n = 290)
were superimposed to identify protein localization in reference to the
bacterial shape.
2.6. Analytical size-exclusion chromatography
The interaction between the puriﬁed recombinant XfTolB and XfPal
proteins was initially evaluated in vitro by analytical size-exclusion
chromatography (SEC) with a Superdex 200 10/300 GL prepacked
column (GE Healthcare, Uppsala, Sweden) as described by Zhang et al.
[17]. Protein sampleswere dialyzed against 50mMTris–Cl pH 8.0 buffer
containing 150 mM NaCl and 1 mM CaCl2 (buffer C), and individual
proteins or a mixture of proteins at equal concentrations (~50 mM)
was incubated for 15 h at 4 °C. Then, individual XfTolB and XfPal
samples and a preincubated isostoichiometric mixture of XfTolB and
XfPalwere separated on the column, whichwas previously equilibrated
with buffer C, at a ﬂow rate of 0.5 mL·min−1. The elution fractions of
each chromatographic run were collected, precipitated with trichloro-
acetic acid and analyzed by 12% SDS-PAGE.
2.7. Small-angle X-ray scattering
The XfTolB–XfPal complex isolated from analytical SEC experiments
was subjected to SAXS. The SAXS data collection was performed at the
SAXS-1 beamline at the Brazilian National Synchrotron Light Laboratory
(LNLS; Campinas, Brazil) [40] using a Dectris-Pilatus (300 K,
84 mm × 107 mm) 2D detector and a monochromatic X-ray beam
with a wavelength of 1.3808 Å. The sample-to-detector distance was
adjusted to 1101.504 mm to cover a momentum transfer interval of
0.01585 b q b 0.44263 Å−1, where q = (4π) · (λ)−1 sin θ and 2θ is
the scattering angle. XfTolB–XfPal complex samples (~1.5 mg·mL−1)
in buffer C were carefully loaded into cells composed of two thin,
parallel mica windows. The scattering patterns of the protein samples
and buffer solution were measured with a 60–300 s exposure time at
4 °C.
Radial integration of the collected images, correction by sample at-
tenuation and normalization relative to the intensity of the transmitted
beam after buffer scattering subtraction were performed using FIT2D
Fig. 1.XfTolB andXfPal are involved inmembrane integrity in E. coli cells. PanelsA–G show
the SDS-associated phenotype in wild-type E. coli and the tolB− and pal− knockout mu-
tants and null mutants complemented with xftolB and xfpal, respectively. (A) The wild-
type, (B) tolB−, (C) pal−, (D) tolB−–xftolB, (E) pal−–xfpal, (F) tolB−–empty pBAD24 and
(G) pal−–empty pBAD24 strains were inoculated on BHI plates supplemented with 0.2%
(w/v) L-arabinose, 30 μg·mL−1 kanamycin (B–G) and 100 μg·mL−1 ampicillin (D–G) at
37 °C. The SDS growth inhibitory effect was assessed using an adapted Kirby–Bauer diffu-
sion test with a 5-mm-diameter ﬁlter paper disc with 5 μL of 10% (w/v) SDS. (H) Growth
curves of thewild-type, knockout strains and nullmutantswith xftolB and xfpal in BHI liq-
uid culture in the presence of 0.2% (w/v) SDS. The growth of the bacterial cells was
assessed by determining the turbidity (OD600) every 15 min for 8 h. All experiments
were performed in triplicate.
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package [42]. The scattering intensity at zero angle I(0) and the Rgwere
calculated from data with low q values (qRg ≤ 1.3) using the indirect
Fourier transform method implemented in GNOM software [43],
which also calculates the distance distribution function P(r) and allows
the assessment of Dmax andmolecule anisometry. Kratky plots of q2I × q
[44,45] were also generated to evaluate the conformational variability
of the protein in solution. The molecular weight of the protein was esti-
mated using the SAXS Mow algorithm [46].
Ab initio dummy beadmodels were calculated from the experimen-
tal curves using the programs DAMMIN and DAMMIF [47,48]. The ﬁnal
low-resolution three-dimensional envelope, which represents the pro-
tein in solution, was generated by averaging independent runs with
DAMAVER and DAMFILT software [49]. The individual and averaged
SAXS envelopes were visually inspected. The low-resolution envelope
from the SAXS experimental curve was superimposed on the available
E. coli TolB–Pal complex crystal structure (PDB code 2HQS) [15] using
PyMOL (PyMOLMolecular Graphics System, version 1.4.1, Schrödinger,
LCC).
The goodness of ﬁt (χ parameter) between the experimental data
and the theoretical scattering curves computed for the possible atomic
model was assessed using CRYSOL software [50]. Structural alignments
were performed using the SUPCOMB software package [51].
3. Results
3.1. Structural X. fastidiosa tol–pal cluster organization and involvement of
XfTolB and XfPal in membrane integrity
Initially, we investigated the structure and organization of the
tol–pal gene cluster in the X. fastidiosa 9a5c strain genome. The struc-
ture of the tol–pal operon is well conserved in Gram-negative bacteria
[9]. The X. fastidiosa tol–pal operon (Supplemental Fig. S1) exhibits the
same organization and size (approximately 6 kb) as that in E. coli,
with the exception of the inclusion of a conserved hypothetical protein
downstream of the gene encoding Pal in X. fastidiosa. This position
should be occupied by ybgF. However, this conserved hypothetical
protein in X. fastidiosa (Xforf_hyp) and YbgF in E. coli (EcYbgF) exhibit
30% amino acid identity (Supplemental Fig. S2). Furthermore, Xforf_hyp
contains a peptide signal comprising amino acid residues 1 to 23
(predicted by SignalP4.1 server; http://www.cbs.dtu.dk/services/
SignalP/), is a bacterial periplasmic space protein with 0.701 certainty
(Psort prediction; http://psort.hgc.jp/form.html) and is predicted to
possess tetratricopeptide repeat-like regions (Smart server; http://
smart.embl-heidelberg.de/). These structural features are shared by
EcYbgF, and based on its chromosome location, this conserved hypo-
thetical protein (Xforf_hyp) is likely YbgF in X. fastidiosa. In addition,
similarly as it occurs in E. coli two distinct gene pairs homologous to
tolQ and tolR also are present in the available X. fastidiosa 9a5c genome.
Due to the high sequence identity of XfTolB (42%) and XfPal (48%)
with their homologs in E. coli, the in vivo functionality of xftolB and
xfpalwas tested using a complementation assay based on the sensitivity
of tolB− and pal− E. colimutants to thedetergent sodiumdodecyl sulfate
(SDS). The E. coli tolB− and pal− knockout strains were complemented
with full-length xftolB and xfpal, respectively, and the inhibitory effect
of SDS on wild-type, null mutants and mutants complemented with
X. fastidiosa genes (Table 1) was assessed. xftolB and xfpal were able to
functionally complement the E. coli mutants (Fig. 1). The wild-type
strain (Fig. 1A) did not exhibit any inhibition of cell growth around
the diffusion ﬁlter disc containing 10% (w/v) SDS in the test performed
on BHI plates. By contrast, a clear inhibition zone was observed for the
tolB− and pal− mutants (Fig. 1B and C, respectively). However, when
these mutants were complemented with xftolB and xfpal under the
control of the araCPBAD arabinose-inducible promoter in pBAD24 [36],
an inhibitory area was not observed (Fig. 1D and E, respectively);
these results were very similar to those observed for the wild-typestrain (Fig. 1A). The null mutants were also complemented with the
empty vector (pBAD24) used to clone xftolB and xfpal as a negative con-
trol for the complementation assays (Fig. 1F and G). Identical results
were obtained for the E. coli knockout mutants (Fig. 1B and C),
conﬁrming the role of xftolB and xfpal in restoring the SDS-associated
phenotype of the mutant strains.
The effect of 0.2% (w/v) SDS on cell growth was also investigated by
determining the turbidity (OD600) of the wild-type, mutants and
mutants complemented with xftolB and xfpal in BHI liquid culture
(Fig. 1H). The cell growth of the mutants complemented with xftolB
and xfpal was similar to that of wild-type in the presence of SDS,
conﬁrming the results obtained on BHI plates (Fig. 1A–G). Not surpris-
ingly, after 4 h of bacterial growth, in the early stationary phase, a
decrease in cell growth was observed for mutants in which the tolB or
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with a defect in the induction of gene expression by arabinose or protein
instability. Nevertheless, the null mutants and mutants complemented
with the empty vector were unable to grow in BHI liquid medium at
SDS concentrations 50 times lower than those used in tests performed
on BHI plates. Therefore, our results conﬁrm the involvement of XfTolB
and XfPal in membrane integrity in vivo.
3.2. Detection and determination of the cellular distribution of XfTolB and
XfPal during X. fastidiosa growth by immunodetection techniques
Recombinant XfTolB protein with a C-terminal His6-tag was cloned,
overexpressed in an E. coli expression host and puriﬁed in this study.
Approximately 25 mg of pure recombinant protein (approximately
95% purity) was obtained per liter of induced bacterial culture. The sec-
ondary folding of the puriﬁed recombinant protein was determinedFig. 2. XfTolB and XfPal immunodetection during X. fastidiosa growth. (A) The proﬁles of XfPal
cells collected during X. fastidiosa bioﬁlm development were determined by (C) XfPal and XfTo
and XfTolB and quantiﬁed using EDAS software. The results (A–B) represent themean of three i
of total X. fastidiosa protein from each bioﬁlm developmental phase and planktonic growthwas
from X. fastidiosa (XfDnaK) was used as a loading control. The error bars indicate the SE of tripl
teins in X. fastidiosa cells after 12 h of the bacterial growth. For each target protein, n = 5 exam
plementary emission of the Cy5 ﬂuorophore (red) measured using a wideﬁeld epiﬂuorescenceprimarily by circular dichroism analysis. The XfTolB circular dichroism
spectrum revealed the presence of a typical secondary structure for a
β-barrel protein (Supplemental Fig. S3), as expected for TolB. The
XfPal protein was produced as described by Santos et al. [37]. The
secondary folding of puriﬁed XfPal was assessed by circular dichroism
and was consistent with previously reported results [37] (data not
shown).
Polyclonal antibodies against XfTolB and XfPal were produced and
used for immunodetection of XfTolB and XfPal during X. fastidiosa
bioﬁlm and planktonic growth and for in vivo immunolabeling
X. fastidiosa cells to determine the subcellular localization of XfTolB
and XfPal (Fig. 2).
We investigated the expression of XfTolB and XfPal between 3 and
30 days of bacterial growth, which comprises the steps from the initial
adhesion of the cells to the surface to be colonized to the last step of
the bioﬁlm development process, the dispersion phase [38].and (B) XfTolB protein expression in bioﬁlm (black circles) and planktonic (open squares)
lB immunoblotting on nitrocellulose membranes using polyclonal antibodies against XfPal
ndependent experiments and are presented in a c-spline interpolation. Approximately 5 μg
resolved on a 12% SDS-PAGE gel prior to immunodetection experiments. TheDnaK protein
icate experiments. (D) Fluorescence based in vivo localization of XfTolB and (E) XfPal pro-
ple images are shown. The bacterial autoﬂuorescence (gray) is superposed with the com-
microscope. Scale bars denote 1 μm.
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planktonic and bioﬁlm modes (Fig. 2C) demonstrated that XfPal and
XfTolB expression differed in these modes. Surprisingly, the expression
proﬁles of XfPal and XfTolB appeared to be dynamic and coordinated
(Fig. 2A and B).When the expression of XfTolB or XfPalwas high during
bioﬁlm growth, its expression was low in the corresponding planktonic
condition, and the conversewas truewhen protein expressionwas high
in the planktonic condition. In addition, the expression proﬁles of XfPal
and XfTolB were similar in a speciﬁc growth mode of X. fastidiosa
(Fig. 2A and B). The expression of XfTolB and XfPal was signiﬁcantly
(P b 0.05, t-test) higher at 3, 5 and 20 days of X. fastidiosa bioﬁlm
development, which correspond to initial bacterial cell surface
adhesion, irreversible adhesion to the surface and mature bioﬁlm,
respectively [38].
To visualize the cellular distribution of the XfPal and XfTolB proteins
during X. fastidiosa growth in vitro, we immunolabeled these proteins
and investigated themusingﬂuorescencemicroscopy. The target XfTolB
and XfPal proteins were located at the apical ends of the X. fastidiosa
cells and/or the center of the bacterial cells (Fig. 2D and E, respectively).
3.3. Characterization and isolation of the recombinant XfTolB–XfPal
complex in vitro
By performing analytical SEC experiments, we isolated the XfTolB–
XfPal complex in vitro (Fig. 3). Initially, individual samples of XfTolB
and XfPal were loaded onto a Superdex 200 10/300 GL column, and
the retention time during the chromatographic runs was determined
for each sample (Fig. 3A). XfTolBwas eluted as a unique peak during an-
alytical SEC assays, while XfPal exhibited two peaks, one corresponding
to an apparent monomeric form and the other resembling a large
oligomer. The XfPal SEC proﬁle is justiﬁed by the fact that the proteinFig. 3.Detection and isolation of the XfTolB–XfPal complex by analytical SEC. (A) Chromatograp
mixture of XfTolB andXfPal. (B) Fractions collected at center peaks 1–3 of theXfTolB, XfPal or XfT
and analyzedby SDS-PAGE. (C) Additional chromatographic separation of the collected central p
collected peak of the XfTolB–XfPal complex in panel C. All chromatographic runs were performwas produced using a refolding protocol and/or intrinsic protein prop-
erties, as previously reported [37].
The preincubated isostoichiometric mixture of XfTolB and XfPal was
subjected to separation by SEC. We observed the following (Fig. 3A):
(i) a decrease in the peak corresponding to XfTolB (Fig. 3A — peak 1);
(ii) a disappearance of the peak corresponding to the monomeric
XfPal fraction (Fig. 3A — peak 2); and (iii) the appearance of an addi-
tional peak that does not match any other peak obtained in the analysis
of the individual samples (Fig. 3A — peak 3). Fractions collected at the
center peaks of the individual XfTolB (Fig. 3A — peak 1) and XfPal
(Fig. 3A — peak 2) samples and the additional peak formed by the
XfTolB–XfPal mixture (Fig. 3A — peak 3) observed in the chromato-
graphic runs were analyzed by SDS-PAGE, which revealed that the
additional peak formed in the XfTolB and XfPal sample (Fig. 3A —
peak 3) represents the retention time of the XfTolB–XfPal complex in
solution (Fig. 3B).
An additional chromatographic run of the sample collected from the
additional peak observed in the XfTolB and XfPal mixture was conduct-
ed to isolate the complex and evaluate its stability. The collected
XfTolB–XfPal complex was eluted as a unique peak during the new
chromatographic run (Fig. 3C), and the presence of unbound individual
XfTolB and XfPal or aggregate protein samples was not observed. Thus,
the XfTolB–XfPal complex was isolated in vitro and is stably maintained
in solution (Fig. 3C and D).
3.4. Overall features of the structural model of the XfTolB–XfPal complex in
solution
We performed SAXS experiments to obtain a low-resolution struc-
ture of the XfTolB–XfPal complex in solution. The SAXS scattering curves
for the XfTolB–XfPal complex isolated by SEC are shown in Fig. 4A.hic runs of the individual XfTolB and XfPal samples and the preincubated isostoichiometric
olB–XfPal complex retention proﬁles in panel Awere precipitatedwith trichloroacetic acid
eak attributed to the XfTolB–XfPal complex (peak3, panel A). (D) SDS-PAGE analysis of the
ed using a Superdex 200 10/300 GL prepacked column at a ﬂow rate of 0.5 mL·min−1.
Fig. 4. SAXS analysis of the XfTolB–XfPal complex in solution. (A) XfTolB–XfPal complex scattering curve. The solid line corresponds to the ﬁtting of the theoretical curve calculated for the
envelope by computationalmethods. A χ value of 1.79was obtainedwith CRYSOL up to a qmax=0.2, as shown in the plot. (B) Linear ﬁtting obtained fromGuinier analysis. (C) Kratky plot
derived from the experimental curves and normalized for I(0) = 1. (D) The distance distribution function P(r) calculated from the experimental curves was used for ab initio envelope
modeling; the higher peak to the left of the center of the range indicates that the XfTolB–XfPal complex exhibits a prolate shape. Negative intensity points in the Kratky plots at higher
q values due to the low sample concentration were subtracted. The plot is limited to the region Iq2 N 0.
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whichwas a result of the analyticalmethodused to separate the complex,
noisier scattering curves were observed at higher angles (q N 0.15 Å−1).
However, the linear behavior of the Guinier plot conﬁrmed the data
quality and sample monodispersity, which are essential for SAXS data
analysis. Five scattering frames with increasing exposure time
(60–300 s) were collected, and the SAXS data presented here (Fig. 4A)
represent the average of the collected curves because all curves exhibited
the same scattering pattern. The XfTolB–XfPal complex Guinier region is
displayed in Fig. 4B. The radius of gyration (Rg) calculated from the linear
regression in the Guinier plot was 29.6 Å. The Kratky plot was also
evaluated (Fig. 4C) and revealed a typical well-deﬁned maximum for a
compact and correctly folded protein. Themolecularmass of the complex
in solution was estimated as 66.3 ± 3 kDa by SAXS Mow software [46].
The estimated molecular weight obtained from SAXS data is consistent
with the expected sum of the molecular masses of recombinant
His6-tag protein XfTolB (monomermass, 46 kDa) and XfPal (monomer
mass, 18 kDa) and conﬁrms that the stoichiometry of the interaction
between TolB and Pal is 1:1. The XfTolB–XfPal complex distance
distribution function P(r) revealed a maximum intramolecular distance
(Dmax) of 100 Å (Fig. 4D). However, the distance peakwas concentrated
at short distances, which indicates a prolate structure. Furthermore,
using the indirect Fourier transform implemented in GNOM [43], the
Rg from the P(r) was more accurately estimated as 30.1 Å, which is
consistent with the values obtained in the Guinier analysis.
The structural model of the XfTolB–XfPal complex in solution recov-
ered from the scattering curves is shown in Fig. 5. This envelope was
superimposed onto the E. coli TolB–Pal complex crystal structure (PDBcode 2HQS) [15], revealing a remarkable ﬁt. The excellent ﬁt and
correctness of the atomic model (Fig. 4A) were conﬁrmed by the chi-
square value of 1.79 obtained for the comparison of the experimental
SAXS curves and the theoretical scattering curves computed for the
XfTolB–XfPal envelope.
4. Discussion
The data presented in this study reveal a dynamic, coordinated
expression proﬁle for XfTolB and XfPal during X. fastidiosa bioﬁlm
growth. We also conﬁrmed the in vivo involvement of XfTolB and
XfPal in membrane integrity using E. colimutants and demonstrate its
cellular localization byﬂuorescencemicroscopy. In addition,we isolated
theXfTolB–XfPal complex in solution and determined its low-resolution
structure for the ﬁrst time.
Although theﬁne details of the physiological function of the proteins
encoded by the tol–pal cluster are not fully understood, its role in the
virulence of several bacteria is increasingly recognized [22–28,30]. The
role of the Tol–Pal system in maintaining cell envelope integrity [5,6]
appears to be conserved in X. fastidiosa, as demonstrated by the ability
of xftolB and xfpal to restore an SDS-associated phenotype in the E. coli
tolB− and pal− knockout strains, respectively.
During evolution, bacteria appear to have selected a wide range of
macromolecules related to the architecture and diversity of the cell
envelope structure [52–54]. In particular, those proteins involved in
membrane integrity that are able tomaintain a cohesive and stable bac-
terial shape, e.g., the Tol–Pal components, and consequently promote
the effective colonization of a habitat directly reﬂect the microbial
Fig. 5. Structural model of the XfTolB–XfPal complex in solution recovered from the SAXS data analysis. The experimental SAXS data were superimposed onto the atomic model of the
E. coli TolB/Pal complex crystal structure (PDB code 2HQS), revealing a remarkable ﬁt. The middle and bottom views are rotated 90° clockwise around the y- and x-axes, respectively.
TolB and Pal from the atomic structure of the E. coli TolB/Pal complex are highlighted in blue and yellow, respectively. The ﬁgures were generated using PyMOL (Schrodinger LLC), and
additional edits were performed using GIMP 2.8 software (http://www.gimp.org/).
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environment, including ionic strength and osmolarity. Thereby, our
ﬁndings indicate that both XfTolB and XfPal may play a variety of pro-
tective and adaptive roles.
Differences in gene expression proﬁles andmetabolomics associated
with bacterial growth in bioﬁlm or planktonic mode, including
P. aeruginosa, Pseudomonas ﬂuorescens and X. fastidiosa, have been re-
ported [28,38,39,55–58]. The temporal expression proﬁle of the tol–pal
mRNAs during the cell division cycle of Caulobacter crescentus indicates
that tolQ, tolR, tolA and tolB expressions are not regulated by the cell
cycle [59]. Although high pal transcript levels are observed in
C. crescentus swarmer cells, Pal protein levels do not exhibit signiﬁcant
changes during the course of the cell cycle [59]. Herein, we report that
XfTolB and XfPal are differentially expressed and exhibit a dynamic, co-
ordinated expression pattern during the bioﬁlm and planktonic modes
of X. fastidiosa growth. The expression level of XfPal as assayed by
immunodetection with an anti-XfPal antibody was considerably higher
than that observed in the XfTolB analyses. However, studies of fraction-
ation and quantiﬁcation focusing on the Tol–Pal components demon-
strated that Pal is present at approximately 2000 to 3000 molecules
per μm2 of cell surface area, corresponding to 8000 to 40,000 copies of
Pal per cell, depending on cell morphology [60]. These results indicate
that Pal plays a major role in outer membrane integrity [5,6,11,60].
Our ﬁndings indicate that XfTolB and XfPal are important in the early
stages of bacterial bioﬁlm development; high amounts of protein were
also detected in the mature bioﬁlm phase. The early stages of
X. fastidiosa bioﬁlm formation are marked by the expression of proteins
involved in substrate adhesion [3,56], and thus the stability of the cell
envelope appears to have a direct impact on the ability of a bacterium
to colonize a particular host, explaining the expression of the Tol–Pal
system in these stages of bioﬁlm development. During the mature
bioﬁlm phase, the growth of the bacterial community is coordinated
and is at its highest level; thus, the high expression of XfTolB andXfPal is not surprising, particularly as the Tol–Pal system may be
involved in the cell division machinery.
The immunoﬂuorescence experiments suggested that XfTolB and
XfPal can occupy the same subcellular localization during X. fastidiosa
growth. Interestingly, by green ﬂuorescent protein fusion, the ﬁve
proteins of the Tol–Pal system (TolQ, TolR, TolA, TolB and Pal) have
been demonstrated to accumulate at cell constriction sites in E. coli
[21]. In the Caulobacter Tol–Pal complex, cryoelectron microscopy
images of tolA-, tolB- and pal-depleted mutants revealed that the cells
failed to complete cell division, highlighting the role of the proteins in
this complex in mediating outer membrane constriction at the last
step of cell division and positioning a protein localization factor [59].
Thus, the visualization of XfTolB and XfPal at the poles and in the center
of the cell suggests that these proteins are involved in the replication of
X. fastidiosa. However, from the immunolabeling data, we cannot con-
ﬁrm conclusively that these proteins accumulate at the cell division
plane in X. fastidiosa. Nevertheless, this is a valuable observation as it
was already reported for some bioﬁlm-forming bacteria as Klebsiella
pneumoniae that the attachment to the substrate occurs at the poles of
the cells [61].
Physical contact between the proteins of the Tol–Pal system is
controversial. An initial study indicated an interaction between Pal
and TolA in vivo [62]. However, a subsequent studywas unable to detect
any interaction between the two proteins in vitro [63]. By contrast, an
in vitro and in vivo interaction between TolB and Pal was detected
early [12,13]. The crystallographic structure of the TolB–Pal complex
from Yersinia pestis (PDB code 4R40) and E. coli is available (PDB code
2HQS) [15], andwe isolated and elucidated the low-resolution structure
of the X. fastidiosa XfTolB–XfPal complex in solution by SAXS. SAXS is a
promising technique to study proteins in solution because it enables
analysis under physiological conditions similar to those in which the
proteins act in vivo and permits the study of protein–protein interac-
tions. The XfTolB–XfPal is a highly stable protein–protein complex that
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distinct two-domain structure comprising an N-terminal mixed α/β
domain and a C-terminal six-bladed β-propeller domain [64], while
Pal comprises a four-stranded mixed β-sheet and four α-helices [15].
Pal bindswithin the bowl formed by connecting strands of the propeller
blades at the C-terminal domain of TolB, yielding a prolate structure
with a unit cell length of a = 74.85 Å, b = 89.05 Å and c = 91.05 Å
[15]. While the XfTolB–XfPal complex in solution exhibits a conﬁgura-
tion similar to that of the 2HQS structure, the former exhibited a Dmax
of 100 Å. Thus, the global rearrangement of TolB and Pal for protein–
protein binding may be more ﬂexible in vivo and affect the ability of
TolB to associate with other proteins in the outer membrane and
periplasm and the ability of Pal to bind to the peptidoglycan layer.
Although attempts to construct X. fastidiosa 9a5c mutants have not
been successful [65,66], partly due to poor growth in classical rich
medium, future studies focusing on the inactivation of the tol–pal gene
cluster will provide new information regarding the role of these genes
during bacteria–plant infection, particularly given the modulation of
host colonization by the blocking of surface attachment by X. fastidiosa
outer membrane vesicles [67]. Furthermore, because XfTolB and XfPal
are involved in membrane integrity and exhibit a dynamic, coordinated
expression proﬁle during the major phases of bacterial bioﬁlm
establishment, these proteins are important targets for the control of
the bioﬁlm development process.
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